Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06192576
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2023-12-20
Brief Title:
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency ASMD
Sponsor:
Sanofi
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-20
First Submit QC Date:
December 20 2023
Study First Post Date:
2024-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-17
Last Update Post Date Type:
ACTUAL